NCT06950164

Brief Summary

The ductus arteriosus quickly closes itself. is an important channel connecting the maternal fetal circulation before birth. After birth, this ductus arteriosus generally no longer has a physical function, so ductus arteriosus quickly closes itself. The persistent presence of ductus arteriosus leads to significant pressure changes in the systemic and pulmonary circulation, which have adverse effects on extremely/very premature infants. Therefore, persistent patent ductus arteriosus (PDA) is a systemic disease.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2025

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

April 22, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 30, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

April 30, 2025

Status Verified

March 1, 2025

Enrollment Period

1.1 years

First QC Date

April 22, 2025

Last Update Submit

April 22, 2025

Conditions

Keywords

pretermpatent ductus arteriosus

Outcome Measures

Primary Outcomes (2)

  • the incidence of patent ductus arteriosus(PDA)

    when did the ductus arteriosus close

    three months after birth

  • dynamic changes of ductus arteriosus in diameter, velocity and direction of blood flow

    dynamic changes of ductus arteriosus in diameter, velocity and direction of blood flow were measured

    after admission, 12 hour, 24 hour, 48 hour, 72 hour, 96 hour, 120 hour, 144 hour, 168 hour, 192 hour, 216 hour, 240 hour and 2 weeks or any time of ductus arteriosus closed

Secondary Outcomes (3)

  • the incidence of bronchopulmonary dysplasia

    36 weeks' gestational age

  • the incidence of intraventricular hemorrhage(IVH)

    36 weeks' gestational age

  • necrotizing enterocolotis(NEC)

    36 weeks' gestational age

Study Arms (2)

observation group

in the group, no intervention was given, and the preterm infants were diagnosed with respiratory distress syndrome(RDS)

Other: observation group

control group

in the group, no intervention was given, but the preterm infants were diagnosed without respiratory distress syndrome(RDS)

Other: control group

Interventions

in the group, no intervention was given, and the preterm infants were diagnosed with respiratory distress syndrome(RDS)

observation group

in the group, no intervention was given, but the preterm infants were diagnosed without respiratory distress syndrome(RDS)

control group

Eligibility Criteria

Age1 Minute - 1 Hour
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

very preterm infants and extremely preterm infants with respiratory distress syndrome (RDS) and without RDS were included.

You may qualify if:

  • less than 32 weeks' gestational age
  • admission with 1 hours after birth

You may not qualify if:

  • congenital abnormalities
  • parents' refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women and Children's hospital of Chonqing Medical University

Chongqing, Chongqing Municipality, 400147, China

Location

MeSH Terms

Conditions

Premature BirthDuctus Arteriosus, Patent

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director

Study Record Dates

First Submitted

April 22, 2025

First Posted

April 30, 2025

Study Start

April 1, 2025

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

April 30, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

after paper published

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
6 months after paper published
Access Criteria
Email to neurochenlong@126.com

Locations